EcoDrugPlus

Nucleotide Binding Oligomerization Domain Containing 2

Ensembl ID : ENSSARG00000013761
Gene Symbol: NOD2
1 External references
166 Possible Orthologues:

Opioid Receptor Kappa 1

Ensembl ID : ENSSARG00000010838
Gene Symbol: OPRK1
3 External references
262 Possible Orthologues:

Opioid Receptor Mu 1

Ensembl ID : ENSSARG00000007778
Gene Symbol: OPRM1
1 External references
214 Possible Orthologues:

Pancreatic Lipase

Ensembl ID : ENSSARG00000011173
Gene Symbol: PNLIP
3 External references
301 Possible Orthologues:

Peptidyl-Prolyl Cis-Trans Isomerase A

Ensembl ID : ENSSARG00000005183
Gene Symbol: LOC101541112
2 External references
309 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSSARG00000009808
Gene Symbol: PPARG
1 External references
406 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha

Ensembl ID : ENSSARG00000008825
Gene Symbol: PIK3CA
1 External references
275 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta

Ensembl ID : ENSSARG00000014063
Gene Symbol: PIK3CB
1 External references
215 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma

Ensembl ID : ENSSARG00000014216
Gene Symbol: PIK3CG
1 External references
213 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSSARG00000013751
Gene Symbol: PDE3B
1 External references
217 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSSARG00000013188
Gene Symbol: PDE4B
1 External references
295 Possible Orthologues:

Phosphodiesterase 4c

Ensembl ID : ENSSARG00000001992
Gene Symbol: PDE4C
1 External references
269 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).